Arcadia Investment Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,333
Closed -$45.8K 299
2024
Q4
$45.8K Buy
+1,333
New +$60.1K 0.01% 225
2024
Q3
Sell
-561
Closed -$33.8K 312
2024
Q2
$33.8K Hold
561
0.01% 221
2024
Q1
$28.9K Hold
561
0.01% 229
2023
Q4
$22.6K Buy
561
+156
+39% +$4.58K ﹤0.01% 251
2023
Q3
$11.3K Buy
+405
New +$12.1K ﹤0.01% 282

Other funds holding RXST

Arcadia Investment Management's RXST Position: Q1 2025 in Review

Arcadia Investment Management sold out of RxSight (RXST) in Q1 2025, closing a stake of 1,333 shares — an estimated $45.8K sold.

Arcadia Investment Management first reported a position in RXST in Q3 2023 and held it in 5 quarters. The position peaked at $45.8K in Q4 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Arcadia Investment Management reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Arcadia Investment Management sold 1,333 RxSight shares in Q1 2025, an estimated $45.8K.
  • Arcadia Investment Management first reported a position in RxSight in Q3 2023 and held it in 5 quarters.
  • Arcadia Investment Management's RxSight position peaked at $45.8K in Q4 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Arcadia Investment Management's 13F filing for Q1 2025, filed 30 Apr 2025.